Jonathan Burdon
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Chemical Health and Safety top 10%
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 8
-
- Protease and Inhibitor Mechanisms 9
- Co-authors
- Kenneth R. Chapman (8 shared papers)Niels Seersholm (7 shared papers)Eeva Piitulainen (7 shared papers)Berend C. Stoel (2 shared papers)Roland Leung (1 shared paper)John B. Carlin (1 shared paper)Daniel Czarny (1 shared paper)Noel G. McElvaney (7 shared papers)
- Journals
- The Medical Journal of Australia (7 papers)Respirology (6 papers)Thorax (3 papers)CHEST Journal (2 papers)Journal of Hepatology (2 papers)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Jonathan Burdon
54 papers receiving 1.1k citations
Jonathan Burdon's Hit Papers
Peers
Comparison fields: 5 of 117
- Cancer Research 270
- Chemical Health and Safety 8
- Microbiology 9
- Pulmonary and Respiratory Medicine 351
- Dermatology 79
Countries citing papers authored by Jonathan Burdon
This map shows the geographic impact of Jonathan Burdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Burdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Burdon more than expected).
Fields of papers citing papers by Jonathan Burdon
This network shows the impact of papers produced by Jonathan Burdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Burdon. The network helps show where Jonathan Burdon may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Burdon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2015 | 329 |
| 2 | 1994 | 127 | |
| 3 | 2012 | 64 | |
| 4 | 1978 | 64 | |
| 5 | 2018 | 48 | |
| 6 | 1996 | 42 | |
| 7 | 2001 | 31 | |
| 8 | 1991 | 31 | |
| 9 | 1996 | 26 | |
| 10 | 1979 | 24 | |
| 11 | 1990 | 23 | |
| 12 | 1977 | 23 | |
| 13 | 1985 | 22 | |
| 14 | 1975 | 21 | |
| 15 | Aerotoxic Syndrome: A New Occupational Disease? | 2017 | 21 |
| 16 | 1997 | 19 | |
| 17 | 1988 | 18 | |
| 18 | 2023 | 18 | |
| 19 | 2010 | 17 | |
| 20 | 1996 | 14 |
About Jonathan Burdon
Jonathan Burdon is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Epidemiology, Molecular Biology and Surgery, having authored 56 papers that have together received 1.1k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Occupational exposure and asthma (4 papers), Peptidase Inhibition and Analysis (4 papers), Asthma and respiratory diseases (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Lung Cancer Research Studies (3 papers) and Chemotherapy-related skin toxicity (3 papers). The work is most often cited by research in Cancer Research (270 citations), Chemical Health and Safety (8 citations), Microbiology (9 citations), Pulmonary and Respiratory Medicine (351 citations) and Dermatology (79 citations). Jonathan Burdon has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Kenneth R. Chapman, Niels Seersholm, Eeva Piitulainen, Berend C. Stoel, Roland Leung, John B. Carlin, Daniel Czarny, Noel G. McElvaney, Robert A. Sandhaus and Jonathan M. Edelman. Their work appears in journals such as The Medical Journal of Australia, Respirology, Thorax, CHEST Journal and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.